With over 30 years of pharmaceutical industry experience, Ponnusamy will lead Alembic’s animal health business strategy, market expansion, and operational growth initiatives
Acquisition of medical equipment distributor aims to strengthen European commercial operations and optimise distribution costs
Notice of Compliance from Health Canada enables marketing authorisation for cancer biosimilar in Canadian market
The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof
New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology
Compared to a net loss of Rs 12 crore in FY25, the pharma major reported a consolidated turnaround in its financial performance
The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay
The company posted revenue of Rs. 703 crore in Q4 FY26
The deal, backed by healthcare investor ARCHIMED, signals a major push to accelerate connected, patient-centered cardiac care worldwide
His appointment is expected to further strengthen the company’s financial governance and regional operational strategy across South Asia
Subscribe To Our Newsletter & Stay Updated
